Market News
Recent Developments
Product Offering
- BD Biosciences, a medical technology company, offers BD FACS Canto Human Macrophage Panel. This panel includes 12 antibodies that target specific macrophage markers, allowing researchers to profile and identify different types of macrophages in a single experiment.
- Abcam, a biotechnology company, offers Human Macrophage Markers Panel. This panel includes 14 antibodies that target specific macrophage markers, making it a valuable tool for researchers studying the role of macrophages in a variety of diseases.
- Thermo Fisher Scientific offers Trucount Human Macrophage Kit. This kit includes reagents and protocols for counting and viability staining of macrophages, providing researchers with a precise and reliable way to measure macrophage populations.
Acquisition and partnership
- On February 14, 2023, Bio-Techne Corporation, a biotechnology company in partnership with Cell Signaling Technology (CST), a life science company, announced the addition of simple western validation to CST antibodies. This will allow researchers in various disciplines an easier way to study important molecular signaling pathways on validated platform. Obtaining accurate data efficiently and quickly is key to advancing drug discovery and development. This partnership will further allow for an expanded menu of Simple Western validated antibodies for various targets across multiple disciplines.
- In October 2022, Thermo Fisher Scientific Inc. announced that it had entered into a definitive agreement to acquire The Binding Site Group, a global leader in specialty diagnostics. The acquisition will further help the company in the expansion of their product as portfolio among clinicians and laboratory professionals worldwide,
U.S.: 
U.K. : 
India : 
